Xiao-Ming Zhang1, Jing Jiao1, Jing Cao1, Xiao-Peng Huo1, Chen Zhu1, Xin-Juan Wu2, Xiao-Hua Xie3. 1. Department of Nursing, Chinese Academy of Medical Sciences - Peking Union Medical College, Peking Union Medical College Hospital (Dongdan campus), Beijing, 100730, China. 2. Department of Nursing, Chinese Academy of Medical Sciences - Peking Union Medical College, Peking Union Medical College Hospital (Dongdan campus), Beijing, 100730, China. wuxinjuan@sina.com. 3. Shenzhen Second People's Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518000, China. 13560779836@163.com.
Abstract
BACKGROUND: A large number of studies have explored the association between frailty and mortality among COVID-19 patients, with inconsistent results. The aim of this meta-analysis was to synthesize the evidence on this issue. METHODS: Three databases, PubMed, Embase, and Cochrane Library, from inception to 20th January 2021 were searched for relevant literature. The Newcastle-Ottawa Scale (NOS) was used to assess quality bias, and STATA was employed to pool the effect size by a random effects model. Additionally, potential publication bias and sensitivity analyses were performed. RESULTS: Fifteen studies were included, with a total of 23,944 COVID-19 patients, for quantitative analysis. Overall, the pooled prevalence of frailty was 51% (95% CI: 44-59%). Patients with frailty who were infected with COVID-19 had an increased risk of mortality compared to those without frailty, and the pooled hazard ratio (HR) and odds ratio (OR) were 1.99 (95% CI: 1.66-2.38) and 2.48 (95% CI: 1.78-3.46), respectively. In addition, subgroup analysis based on population showed that the pooled ORs for hospitalized patients in eight studies and nursing home residents in two studies were 2.62 (95% CI: 1.68-4.07) and 2.09 (95% CI: 1.40-3.11), respectively. Subgroup analysis using the frailty assessment tool indicated that this association still existed when using the clinical frailty scale (CFS) (assessed in 6 studies, pooled OR = 2.88, 95% CI: 1.52-5.45; assessed in 5 studies, pooled HR = 1.99, 95% CI: 1.66-2.38) and other frailty tools (assessed in 4 studies, pooled OR = 1.98, 95% CI: 1.81-2.16). In addition, these significant positive associations still existed in the subgroup analysis based on study design and geographic region. CONCLUSION: Our study indicates that frailty is an independent predictor of mortality among patients with COVID-19. Thus, frailty could be a prognostic factor for clinicians to stratify high-risk groups and remind doctors and nurses to perform early screening and corresponding interventions urgently needed to reduce mortality rates in patients infected by SARS-CoV-2.
BACKGROUND: A large number of studies have explored the association between frailty and mortality among COVID-19patients, with inconsistent results. The aim of this meta-analysis was to synthesize the evidence on this issue. METHODS: Three databases, PubMed, Embase, and Cochrane Library, from inception to 20th January 2021 were searched for relevant literature. The Newcastle-Ottawa Scale (NOS) was used to assess quality bias, and STATA was employed to pool the effect size by a random effects model. Additionally, potential publication bias and sensitivity analyses were performed. RESULTS: Fifteen studies were included, with a total of 23,944 COVID-19patients, for quantitative analysis. Overall, the pooled prevalence of frailty was 51% (95% CI: 44-59%). Patients with frailty who were infected with COVID-19 had an increased risk of mortality compared to those without frailty, and the pooled hazard ratio (HR) and odds ratio (OR) were 1.99 (95% CI: 1.66-2.38) and 2.48 (95% CI: 1.78-3.46), respectively. In addition, subgroup analysis based on population showed that the pooled ORs for hospitalized patients in eight studies and nursing home residents in two studies were 2.62 (95% CI: 1.68-4.07) and 2.09 (95% CI: 1.40-3.11), respectively. Subgroup analysis using the frailty assessment tool indicated that this association still existed when using the clinical frailty scale (CFS) (assessed in 6 studies, pooled OR = 2.88, 95% CI: 1.52-5.45; assessed in 5 studies, pooled HR = 1.99, 95% CI: 1.66-2.38) and other frailty tools (assessed in 4 studies, pooled OR = 1.98, 95% CI: 1.81-2.16). In addition, these significant positive associations still existed in the subgroup analysis based on study design and geographic region. CONCLUSION: Our study indicates that frailty is an independent predictor of mortality among patients with COVID-19. Thus, frailty could be a prognostic factor for clinicians to stratify high-risk groups and remind doctors and nurses to perform early screening and corresponding interventions urgently needed to reduce mortality rates in patientsinfected by SARS-CoV-2.
Authors: John E Morley; Bruno Vellas; G Abellan van Kan; Stefan D Anker; Juergen M Bauer; Roberto Bernabei; Matteo Cesari; W C Chumlea; Wolfram Doehner; Jonathan Evans; Linda P Fried; Jack M Guralnik; Paul R Katz; Theodore K Malmstrom; Roger J McCarter; Luis M Gutierrez Robledo; Ken Rockwood; Stephan von Haehling; Maurits F Vandewoude; Jeremy Walston Journal: J Am Med Dir Assoc Date: 2013-06 Impact factor: 4.669
Authors: Jonathan Hewitt; Ben Carter; Arturo Vilches-Moraga; Terence J Quinn; Philip Braude; Alessia Verduri; Lyndsay Pearce; Michael Stechman; Roxanna Short; Angeline Price; Jemima T Collins; Eilidh Bruce; Alice Einarsson; Frances Rickard; Emma Mitchell; Mark Holloway; James Hesford; Fenella Barlow-Pay; Enrico Clini; Phyo K Myint; Susan J Moug; Kathryn McCarthy Journal: Lancet Public Health Date: 2020-06-30
Authors: Donogh Maguire; Marylynne Woods; Conor Richards; Ross Dolan; Jesse Wilson Veitch; Wei M J Sim; Olivia E H Kemmett; David C Milton; Sophie L W Randall; Ly D Bui; Nicola Goldmann; Allan Cameron; Barry Laird; Dinesh Talwar; Ian Godber; Alan Davidson; Donald C McMillan Journal: J Transl Med Date: 2020-09-15 Impact factor: 5.531
Authors: Marta Cobos-Siles; Pablo Cubero-Morais; Irene Arroyo-Jiménez; María Rey-Hernández; Laura Hernández-Gómez; Derly Judith Vargas-Parra; María González-Fernández; Marina Cazorla-González; Miriam Gabella-Martín; Tomás Ruíz-Albi; José Angel Berezo-García; Jesús Fernando García-Cruces-Méndez; José Pablo Miramontes-González; Luis Corral-Gudino Journal: Intern Emerg Med Date: 2020-09-10 Impact factor: 3.397
Authors: Sara Hägg; Juulia Jylhävä; Yunzhang Wang; Hong Xu; Carina Metzner; Martin Annetorp; Sara Garcia-Ptacek; Masih Khedri; Anne-Marie Boström; Ahmadul Kadir; Anna Johansson; Miia Kivipelto; Maria Eriksdotter; Tommy Cederholm; Dorota Religa Journal: J Am Med Dir Assoc Date: 2020-08-14 Impact factor: 7.802
Authors: Magdalena Jachymek; Aleksandra Cader; Michał Ptak; Wojciech Witkiewicz; Adam Grzegorz Szymański; Katarzyna Kotfis; Jarosław Kaźmierczak; Aleksandra Szylińska Journal: Int J Environ Res Public Health Date: 2022-01-19 Impact factor: 3.390
Authors: Arielle Elkrief; Cassandra Hennessy; Nicole M Kuderer; Samuel M Rubinstein; Elizabeth Wulff-Burchfield; Rachel P Rosovsky; Karen Vega-Luna; Michael A Thompson; Orestis A Panagiotou; Aakash Desai; Donna R Rivera; Ali Raza Khaki; Lisa Tachiki; Ryan C Lynch; Catherine Stratton; Rawad Elias; Gerald Batist; Anup Kasi; Dimpy P Shah; Ziad Bakouny; Angelo Cabal; Jessica Clement; Jennifer Crowell; Becky Dixon; Christopher R Friese; Stacy L Fry; Punita Grover; Shuchi Gulati; Shilpa Gupta; Clara Hwang; Hina Khan; Soo Jung Kim; Elizabeth J Klein; Chris Labaki; Rana R McKay; Amanda Nizam; Nathan A Pennell; Matthew Puc; Andrew L Schmidt; Armin Shahrokni; Justin A Shaya; Christopher T Su; Sarah Wall; Nicole Williams; Trisha M Wise-Draper; Sanjay Mishra; Petros Grivas; Benjamin French; Jeremy L Warner; Tanya M Wildes Journal: Lancet Healthy Longev Date: 2022-02-14
Authors: Gian Luca Salvagno; Brandon M Henry; Giovanni di Piazza; Laura Pighi; Simone De Nitto; Damiano Bragantini; Gian Luca Gianfilippi; Giuseppe Lippi Journal: Diagnostics (Basel) Date: 2021-05-04
Authors: Marcello Covino; Giuseppe De Matteis; Davide Della Polla; Maria Livia Burzo; Marco Maria Pascale; Michele Santoro; Raimondo De Cristofaro; Antonio Gasbarrini; Erica De Candia; Francesco Franceschi Journal: Aging Clin Exp Res Date: 2021-07-03 Impact factor: 3.636
Authors: Leszek Tylicki; Ewelina Puchalska-Reglińska; Piotr Tylicki; Aleksander Och; Karolina Polewska; Bogdan Biedunkiewicz; Aleksandra Parczewska; Krzysztof Szabat; Jacek Wolf; Alicja Dębska-Ślizień Journal: J Clin Med Date: 2022-01-06 Impact factor: 4.241